Clinical Trial Update: Ertapenem Administered Subcutaneously Versus Intravenously [Phase 3]

View source ↗

Summary

Phase 3 trial comparing subcutaneous versus intravenous administration of ertapenem for urinary tract infections was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• ERTAPENEM (ertapenem)

Snippet

Sponsor: Instituto Nacional de Cancer, Brazil | Conditions: Urinary Tract Infections | Phase 3 | Status: TERMINATED